Edgewise Therapeutics
Katherine Wilcox is currently serving as the Associate Director of Clinical Data Management at Edgewise Therapeutics. Prior to this role, Katherine held positions at Clinipace, Marcus Autism Center, Emory University, UHS Pruitt Corporation, and The University of Alabama. Katherine has extensive experience in managing clinical data across various trials and projects, demonstrating strong leadership skills and expertise in data management, analysis, and publication writing. Katherine holds a Master's Degree in Public Health with a concentration in Epidemiology from Emory University and a Bachelor of Science degree in Biology/Biological Sciences from The University of Alabama.
This person is not in any offices
Edgewise Therapeutics
1 followers
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it’s Series B financing round which will support the advancement of Edgewise Therapeutic’s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company’s pipeline. The company’s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.